
Funding from the U.S. President’s Emergency Plan for AIDS Relief helps staff at Kenya’s Children of God Relief Institute manage the facility and evaluate the project’s aim—to deliver high quality, high impact pediatric and adolescent HIV care.
Back to the drawing board: The FACTS 001 trial, a study to test whether tenofovir gel could prevent HIV infection, did not confirm the gel’s effectiveness. While these results are disappointing, USAID is supporting the development of many other promising solutions, including vaginal rings and long-acting injectables.